Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Dysplasia 2Squamous Intraepithelial Lesions 2

Interventions

Watchful Waiting 2VGX-3100 2Light Coagulation 2Imiquimod 2Fluorouracil 2Observation 1Laser Therapy 1Electroporation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Squamous Intraepithelial Lesions × VGX-3100 × Clear all
NCT03721978 2024-10-17

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Inovio Pharmaceuticals

Phase 3 Completed
203 enrolled 34 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

NCT03185013 2023-07-27

REVEAL 1

Inovio Pharmaceuticals

Phase 3 Completed
201 enrolled 23 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡